Business Summary

Dermisonics, Inc.

We have for sale a clean SEC non reporting corporate shell (non shell status) with good prior operating history and debt in friendly hands.Essentiallythe co will have no liabilities once the new owner steps in. The debt is convertible. The current capitalization of the Company consists of the following classes of capital stock:

* Common stock, $ 0.001 par value: 10,000,000,000 shares authorized; 5,217,475,719 shares issued and outstanding

We are offering you 100% of the Company's issuedpreferredshares (the Control Block) and outstanding common stock issued to the current operating subsidiary. The share price does not reflect true values. We are selling the control block in exchange for $80,000. Included in this price is also the next 10-Q filing with XBRL, Super 8-K filing, Schedule 14F, Schedule 13D, and name change if requested if so required. Upon sale/merger, the sole director and all officers will resign and you can nominate your own directors.

ADVANTAGES

A domestic private company can take advantage of Regulation 506 D and give accredited investors a clear liquidity strategy! You can complete a Reg. 506 D offering before or after you merge with and into our corporate shell. We will then help you file a resale registration statement, SEC Form S-1. If you have 35+ shareholders, business plan, and audited financials, we can help you get a market maker to file Form 211 with FINRA to get stock symbol, apply for CUSIP # and get trading in the Over-the Counter Marketplace such as the OTC Markets (Pink Sheets).
A foreign company can easily take advantage of Regulation S (Non US investors) to achieve a shareholder base and then file an S-1 or utilize an exemption such as Rule 144.

Property Details